Registration - Amendment

340B HEALTH for 340B HEALTH

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

HR 2606 and S 1376. Extending 340B Drug Pricing to Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs

LobbyistCovered position, as disclosed
STUART YAEL GORDON New —
ANNA MANGUM New —
ROBERT RECKLAUS New —
TED SLAFSKY New —
JAIMIE VICKERY New —
WILLIAM VON OEHSEN New —
BONNIE WEINTRAUB New —

Bills named: H.R. 2606 (110th)

Health Issues HCR

HR 2606 and S 1376. Extending 340B Drug Pricing to Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs

LobbyistCovered position, as disclosed
STUART YAEL GORDON New —
ANNA MANGUM New —
ROBERT RECKLAUS New —
TED SLAFSKY New —
JAIMIE VICKERY New —
WILLIAM VON OEHSEN New —
BONNIE WEINTRAUB New —

Bills named: H.R. 2606 (110th)

Affiliated organisations

OrganisationLocation
HOLLAND AND KNIGHT Washington, DC, US
MCALLISTER & QUINN Washington, DC, US
POWERS PYLES SUTTER & VERILLE Washington, DC, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.